Jiangsu Hengrui Medicine
600276.SS
#469
Rank
NZ$74.05 B
Marketcap
$11.61
Share price
-1.89%
Change (1 day)
5.85%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$21.31 Million

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is NZ$21.31 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31NZ$0.31 B791.62%
2021-12-31NZ$34.82 M
2015-12-31NZ$2.26 M9.7%
2014-12-31NZ$2.06 M-48.75%
2013-12-31NZ$4.02 M106.27%
2012-12-31NZ$1.94 M-52.18%
2011-12-31NZ$4.07 M4%
2010-12-31NZ$3.92 M94.5%
2009-12-31NZ$2.01 M
2007-12-31NZ$10.73 M23.03%
2006-12-31NZ$8.72 M0.28%
2005-12-31NZ$8.7 M-48.14%
2004-12-31NZ$16.78 M-76.27%
2003-12-31NZ$70.72 M19.44%
2002-12-31NZ$59.21 M-19.21%
2001-12-31NZ$73.29 M47.16%
2000-12-31NZ$49.8 M4.96%
1999-12-31NZ$47.45 M45.42%
1998-12-31NZ$32.63 M21.38%
1997-12-31NZ$26.88 M